Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. Other Scholarly Work

Castellanos, Daniel, Gralnik, Leonard M. (2016). Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. . 5(1), 16-24. 10.5409/wjcp.v5.i1.16

cited authors

  • Castellanos, Daniel; Gralnik, Leonard M

abstract

  • Synthetic cannabinoids are a group of substances in the world of designer drugs that have become increasingly popular over the past few years. Synthetic cannabinoids are a chemically diverse group of compounds functionally similar to THC. Since first appearing on the world market a few years ago these compounds have evolved rapidly. Newer more potent analogues have been developed. Identifying youth who abuse these substances can be difficult. Newer forms of consumption have also evolved. These products are now manufactured in products that look like natural cannabis resin and in liquid cartridges used in electronic cigarettes. Synthetic cannabinoids appear to be associated with potentially dangerous health effects that are more severe than that of marijuana. Some synthetic cannabinoid compounds have been associated with serious physical consequences, such as, seizures, myocardial infarction and renal damage. In addition, psychoactive effects, such as aggression, confusion, anxiety and psychosis have also been reported. The diagnosis remains primarily clinical with toxicological confirmation difficult due to manufacturers constantly developing new analogues to avoid detection. Pediatricians are urged to familiarize themselves with these drugs and the typical presentations of patients who use them.

publication date

  • February 8, 2016

Digital Object Identifier (DOI)

Medium

  • Electronic-eCollection

start page

  • 16

end page

  • 24

volume

  • 5

issue

  • 1